Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 146,000 | 188,000 | 196,000 | 319,000 | 587,000 |
| Receivables | 1,608,000 | 1,548,000 | 1,472,000 | 1,275,000 | 1,183,000 |
| Inventories | 1,166,000 | 1,078,000 | 955,000 | 1,016,000 | 946,000 |
| Income taxes - deferred | N/A | N/A | 75,000 | 496,000 | 447,000 |
| Other current assets | 922,000 | 942,000 | 541,000 | 365,000 | 443,000 |
| TOTAL | $4,003,000 | $3,822,000 | $3,239,000 | $3,471,000 | $3,606,000 |
| Non-Current Assets | |||||
| PPE Net | 1,782,000 | 1,697,000 | 1,630,000 | 1,490,000 | 1,507,000 |
| Intangibles | 14,283,000 | 12,835,000 | 12,561,000 | 12,667,000 | 11,504,000 |
| Other Non-Current Assets | 932,000 | 688,000 | 666,000 | 505,000 | 407,000 |
| TOTAL | $16,997,000 | $15,220,000 | $14,857,000 | $14,662,000 | $13,418,000 |
| Total Assets | $20,999,000 | $19,042,000 | $18,096,000 | $18,133,000 | $17,024,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 1,801,000 | 64,000 | 3,000 | 403,000 |
| Accounts payable and accrued liabilities | 349,000 | 530,000 | 447,000 | 209,000 | 262,000 |
| Accrued Expenses | 2,246,000 | 2,456,000 | 2,312,000 | 1,970,000 | 1,950,000 |
| Other current liabilities | 412,000 | 867,000 | 764,000 | 248,000 | 231,000 |
| TOTAL | $5,260,000 | $5,654,000 | $3,587,000 | $2,430,000 | $2,846,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,803,000 | 3,815,000 | 5,420,000 | 5,674,000 | 3,841,000 |
| Other Non-Current Liabilities | 1,882,000 | 2,370,000 | 2,338,000 | 2,974,000 | 2,666,000 |
| TOTAL | $7,013,000 | $6,376,000 | $7,776,000 | $9,383,000 | $7,721,000 |
| Total Liabilities | $12,273,000 | $12,030,000 | $11,363,000 | $11,813,000 | $10,567,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,385,962 | 1,374,911 | 1,363,489 | 1,348,346 | 1,330,512 |
| Common Shares | 16,000 | 16,000 | 16,000 | 16,000 | 16,000 |
| Retained earnings | -6,953,000 | -8,390,000 | -8,581,000 | -8,927,000 | -8,689,000 |
| Other shareholders' equity | 34,000 | -58,000 | 1,000 | 88,000 | 144,000 |
| TOTAL | $8,726,000 | $7,012,000 | $6,733,000 | $6,320,000 | $6,457,000 |
| Total Liabilities And Equity | $20,999,000 | $19,042,000 | $18,096,000 | $18,133,000 | $17,024,000 |